Peter Graham - Mar 3, 2022 Form 4 Insider Report for ANTARES PHARMA, INC. (ATRS)

Signature
/s/ Lisa M. Kallebo as attorney-in-fact for Peter J. Graham
Stock symbol
ATRS
Transactions as of
Mar 3, 2022
Transactions value $
-$51,813
Form type
4
Date filed
3/4/2022, 05:34 PM
Previous filing
Feb 18, 2022
Next filing
May 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRS Common Stock Award $0 +26K +4.31% $0.00 630K Mar 3, 2022 Direct F1
transaction ATRS Common Stock Tax liability -$51.8K -13.6K -2.16% $3.80 617K Mar 3, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 13, 2019, Mr. Graham was granted a performance stock unit award that was contingent upon achieving certain performance goals over the three-year performance period ended December 31, 2021. The number of shares acquired represent the total number of shares earned upon achievement of one of the performance goals, which was certified and vested on March 3, 2022. The shares of common stock disposed represents the number of shares withheld by the company to settle tax liabilities in connection with the vesting of the performance stock unit award and were not actually sold.